Law360, New York ( August 4, 2015, 9:18 AM EDT) -- Patent prosecutors strive to optimize protection afforded by pharmaceutical patents for branded pharmaceutical clients. For reasons discussed herein, one underappreciated way to optimize pharmaceutical patent protection is to successfully address a restriction requirement (or lack of unity of invention counterpart) raised by a U.S. Patent and Trademark Office examiner during a patent examination....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.